Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia

Morphological and functional evidence for increased peroxynitrite formation

Zoltan Ungvari, Anna Csiszar, Zsolt Bagi, Akos Koller

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Hyperhomocysteinemia (HHcy) is a newly recognized risk factor for myocardial infarction, however, the effect of HHcy on endothelium-dependent flow-induced dilation of coronary arteries is not known. Thus, changes in diameter of small intramural coronary arteries (diameter, ∼145 μm) isolated from control rats and rats with methionine diet-induced HHcy were investigated by videomicroscopy. Increases in intraluminal flow (from 0 to 40 μl/min) elicited dilations of control vessels (maximum, 25 ± 2 μm), responses that were absent in HHcy arteries. The nitric oxide (NO) synthase inhibitor L-NAME inhibited flow-induced dilation of control coronaries, whereas it had no effect on responses of HHcy arteries. Dilations of control and HHcy arteries to the NO donor sodium nitroprusside were not different. Responses to flow in HHcy coronary arteries were unaffected by administration of L-arginine or the prostaglandin H2/thromboxane A2 receptor antagonist SQ 29,548. However, in the presence of superoxide dismutase (plus catalase) or the superoxide scavenger Tiron increases in flow elicited L-NAME-sensitive dilations of HHcy coronaries (maximum, 18 ± 5 μm). Also, superoxide dismutase significantly reduced the enhanced superoxide production of HHcy coronaries (measured by the lucigenin chemiluminescence method). Single vessel Western blotting showed an increased tyrosine nitrosation (a stable biomarker of tissue peroxynitrite formation) in HHcy coronaries. Also, extensive prevalence of 3-nitrotyrosine immunoreactivity was observed in HHcy coronaries that was confined primarily to the subendothelial layers of smooth muscle. We propose that in HHcy an increased level of superoxide scavenges NO forming peroxynitrite, which increases protein nitrosation. The reduced bioavailability of NO impairs flow-induced dilations of coronary arteries, which may contribute to the development of coronary atherosclerosis and ischemic heart disease.

Original languageEnglish (US)
Pages (from-to)145-153
Number of pages9
JournalAmerican Journal of Pathology
Volume161
Issue number1
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Hyperhomocysteinemia
Peroxynitrous Acid
Dilatation
Nitric Oxide
Coronary Vessels
Superoxides
Nitrosation
Arteries
NG-Nitroarginine Methyl Ester
Superoxide Dismutase
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
Prostaglandin H2 Receptors Thromboxane A2
Video Microscopy
Nitric Oxide Donors
Nitroprusside
Luminescence
Nitric Oxide Synthase
Methionine
Catalase
Biological Availability

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia : Morphological and functional evidence for increased peroxynitrite formation. / Ungvari, Zoltan; Csiszar, Anna; Bagi, Zsolt; Koller, Akos.

In: American Journal of Pathology, Vol. 161, No. 1, 01.01.2002, p. 145-153.

Research output: Contribution to journalArticle

@article{86b4b238019943d9a5b4c85b6b32d366,
title = "Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: Morphological and functional evidence for increased peroxynitrite formation",
abstract = "Hyperhomocysteinemia (HHcy) is a newly recognized risk factor for myocardial infarction, however, the effect of HHcy on endothelium-dependent flow-induced dilation of coronary arteries is not known. Thus, changes in diameter of small intramural coronary arteries (diameter, ∼145 μm) isolated from control rats and rats with methionine diet-induced HHcy were investigated by videomicroscopy. Increases in intraluminal flow (from 0 to 40 μl/min) elicited dilations of control vessels (maximum, 25 ± 2 μm), responses that were absent in HHcy arteries. The nitric oxide (NO) synthase inhibitor L-NAME inhibited flow-induced dilation of control coronaries, whereas it had no effect on responses of HHcy arteries. Dilations of control and HHcy arteries to the NO donor sodium nitroprusside were not different. Responses to flow in HHcy coronary arteries were unaffected by administration of L-arginine or the prostaglandin H2/thromboxane A2 receptor antagonist SQ 29,548. However, in the presence of superoxide dismutase (plus catalase) or the superoxide scavenger Tiron increases in flow elicited L-NAME-sensitive dilations of HHcy coronaries (maximum, 18 ± 5 μm). Also, superoxide dismutase significantly reduced the enhanced superoxide production of HHcy coronaries (measured by the lucigenin chemiluminescence method). Single vessel Western blotting showed an increased tyrosine nitrosation (a stable biomarker of tissue peroxynitrite formation) in HHcy coronaries. Also, extensive prevalence of 3-nitrotyrosine immunoreactivity was observed in HHcy coronaries that was confined primarily to the subendothelial layers of smooth muscle. We propose that in HHcy an increased level of superoxide scavenges NO forming peroxynitrite, which increases protein nitrosation. The reduced bioavailability of NO impairs flow-induced dilations of coronary arteries, which may contribute to the development of coronary atherosclerosis and ischemic heart disease.",
author = "Zoltan Ungvari and Anna Csiszar and Zsolt Bagi and Akos Koller",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)64166-1",
language = "English (US)",
volume = "161",
pages = "145--153",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia

T2 - Morphological and functional evidence for increased peroxynitrite formation

AU - Ungvari, Zoltan

AU - Csiszar, Anna

AU - Bagi, Zsolt

AU - Koller, Akos

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Hyperhomocysteinemia (HHcy) is a newly recognized risk factor for myocardial infarction, however, the effect of HHcy on endothelium-dependent flow-induced dilation of coronary arteries is not known. Thus, changes in diameter of small intramural coronary arteries (diameter, ∼145 μm) isolated from control rats and rats with methionine diet-induced HHcy were investigated by videomicroscopy. Increases in intraluminal flow (from 0 to 40 μl/min) elicited dilations of control vessels (maximum, 25 ± 2 μm), responses that were absent in HHcy arteries. The nitric oxide (NO) synthase inhibitor L-NAME inhibited flow-induced dilation of control coronaries, whereas it had no effect on responses of HHcy arteries. Dilations of control and HHcy arteries to the NO donor sodium nitroprusside were not different. Responses to flow in HHcy coronary arteries were unaffected by administration of L-arginine or the prostaglandin H2/thromboxane A2 receptor antagonist SQ 29,548. However, in the presence of superoxide dismutase (plus catalase) or the superoxide scavenger Tiron increases in flow elicited L-NAME-sensitive dilations of HHcy coronaries (maximum, 18 ± 5 μm). Also, superoxide dismutase significantly reduced the enhanced superoxide production of HHcy coronaries (measured by the lucigenin chemiluminescence method). Single vessel Western blotting showed an increased tyrosine nitrosation (a stable biomarker of tissue peroxynitrite formation) in HHcy coronaries. Also, extensive prevalence of 3-nitrotyrosine immunoreactivity was observed in HHcy coronaries that was confined primarily to the subendothelial layers of smooth muscle. We propose that in HHcy an increased level of superoxide scavenges NO forming peroxynitrite, which increases protein nitrosation. The reduced bioavailability of NO impairs flow-induced dilations of coronary arteries, which may contribute to the development of coronary atherosclerosis and ischemic heart disease.

AB - Hyperhomocysteinemia (HHcy) is a newly recognized risk factor for myocardial infarction, however, the effect of HHcy on endothelium-dependent flow-induced dilation of coronary arteries is not known. Thus, changes in diameter of small intramural coronary arteries (diameter, ∼145 μm) isolated from control rats and rats with methionine diet-induced HHcy were investigated by videomicroscopy. Increases in intraluminal flow (from 0 to 40 μl/min) elicited dilations of control vessels (maximum, 25 ± 2 μm), responses that were absent in HHcy arteries. The nitric oxide (NO) synthase inhibitor L-NAME inhibited flow-induced dilation of control coronaries, whereas it had no effect on responses of HHcy arteries. Dilations of control and HHcy arteries to the NO donor sodium nitroprusside were not different. Responses to flow in HHcy coronary arteries were unaffected by administration of L-arginine or the prostaglandin H2/thromboxane A2 receptor antagonist SQ 29,548. However, in the presence of superoxide dismutase (plus catalase) or the superoxide scavenger Tiron increases in flow elicited L-NAME-sensitive dilations of HHcy coronaries (maximum, 18 ± 5 μm). Also, superoxide dismutase significantly reduced the enhanced superoxide production of HHcy coronaries (measured by the lucigenin chemiluminescence method). Single vessel Western blotting showed an increased tyrosine nitrosation (a stable biomarker of tissue peroxynitrite formation) in HHcy coronaries. Also, extensive prevalence of 3-nitrotyrosine immunoreactivity was observed in HHcy coronaries that was confined primarily to the subendothelial layers of smooth muscle. We propose that in HHcy an increased level of superoxide scavenges NO forming peroxynitrite, which increases protein nitrosation. The reduced bioavailability of NO impairs flow-induced dilations of coronary arteries, which may contribute to the development of coronary atherosclerosis and ischemic heart disease.

UR - http://www.scopus.com/inward/record.url?scp=0036309974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036309974&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)64166-1

DO - 10.1016/S0002-9440(10)64166-1

M3 - Article

VL - 161

SP - 145

EP - 153

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -